Genedata has released Genedata Screener 5.5, its enterprise solution for high throughput and high content screening analysis.
The Screener platform combines enterprise-wide assay data management with high-performance processing workflows and flexible analysis tools. Screener rapidly analyses, integrates and manages all assay data, independent of instrumentation, technology, volume or location. The findings are then combined with chemical, pharmacological and in vivo data to support scientists in the tasks of compound prioritisation and identification of quality lead structures with the highest confidence.
Screener 5.5 features easy integration of pharmacological fit models and advanced functionality for analyzing experiments with multiple readouts. Users will greatly benefit from the ability to integrate new fit models that are relevant for their particular workflows, such as the Morrison equation for Ki fitting, or new proprietary and public fit algorithms. In addition, the open and scalable architecture extends Screener’s applicability as enterprise screening analysis platform, from uHTS centers to therapeutic areas, and provides access to a wide range of information in corporate research and drug discovery systems.